PuSH - Publication Server of Helmholtz Zentrum München

57 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Hörber, S. ; Achenbach, P. ; Schleicher, E. & Peter, A.: Harmonization of immunoassays for biomarkers in diabetes mellitus. Biotechnol. Adv., accepted (2019)
Kick, K. & Achenbach, P.: Infektionen in der Schwangerschaft und frühen Kindheit. Risiko für Betazell-Autoimmunität und Typ-1-Diabetes? Diabetes akt. 17, 110-112 (2019)
Winkler, C. et al.: Age, HLA, and sex define a marked risk of organ-specific autoimmunity in first-degree relatives of patients with type 1 diabetes. Diabetes Care, accepted (2019)
Ziegler, A.-G. et al.: Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. BMJ Open 9:e028578 (2019)
Achenbach, P. et al.: Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12. Diabetologia 61, 1644-1649 (2018)
Achenbach, P.: Früherkennung und präventive Behandlung des Typ-1-Diabetes. Diabetologe 14, 212-213 (2018)
Achenbach, P.: Typ-1-Diabetes im asymptomatischen Frühstadium: Orales Insulin zur präventiven Behandlung. Diabetologe 14, 234-239 (2018)
Endesfelder, D. et al.: Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119-130 (2018)
Heinrich, M. et al.: Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetes. Pediatr. Diabetes 19, 1238-1242 (2018)
Kick, K.* et al.: Recruiting young pre-symptomatic children for a clinical trial in type 1 diabetes: Insights from the Fr1da insulin intervention study. Contemp. Clin. Trails Comm. 11, 170-173 (2018)
Kick, K.* et al.: Feasibility and organization of a population-based screening for pre-symptomatic type 1 diabetes in children – Evaluation of the Fr1da study. J. Public Health, accepted (2018)
Liberati, D.* et al.: A novel LIPS assay for insulin autoantibodies. Acta Diabetol. 55, 263–270 (2018)
Long, A.E.* et al.: Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: The SNAIL study. Diabetologia 61, 1484–1490 (2018)
Mathieu, C.* ; Lahesmaa, R.* ; Bonifacio, E. ; Achenbach, P. & Tree, T.*: Immunological biomarkers for the development and progression of type 1 diabetes. Diabetologia 61, 2252-2258 (2018)
Tavira, B.* et al.: Intralymphatic glutamic acid decarboxylase (GAD)-alum administration induced Th2-like specific immunomodulation in responder patients: a pilot clinical trial in type 1 diabetes. J. Diabetes Res. 2018, 9391845 (2018)
Wyatt, R.C.* et al.: The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes. Diabetic Med. 35, 954-963 (2018)
Goerdes, L.* ; Achenbach, P. ; Roden, M.* & Muessig, K.*: Eine seltene Ursache für eine hyperinsulinämische Hypoglykämie. Diabetol. Stoffwechs. 12, 184-185 (2017)
von Toerne, C. et al.: Peptide serum markers in islet autoantibody-positive children. Diabetologia 60, 287-295 (2017)
Amoroso, M.* et al.: 3 screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD65, TO IA-2 and TO ZnT8. Clin. Chim. Acta 462, 60-64 (2016)
Endesfelder, D. et al.: Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome 4:17 (2016)